The NEAT Study: A 48-Week Open-Label Study to Compare the Antiviral Efficacy and Safety of GW433908 Versus Nelfinavir in Antiretroviral Therapy???Naive HIV-1-Infected Patients-Reference-Cited by-同舟云学术

The NEAT Study: A 48-Week Open-Label Study to Compare the Antiviral Efficacy and Safety of GW433908 Versus Nelfinavir in Antiretroviral Therapy???Naive HIV-1-Infected Patients

Published:2004-01 Issue:1 Volume:35 Page:22-32
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes

Author:

Rodriguez-French Amalia,Boghossian Jack,Gray Glenda E.,Nadler Jeffrey P.,Quinones Arnaldo R.,Sepulveda Gladys E.,Millard Judith M.,Wannamaker Paul G.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference14 articles.

1. Pharmacokinetics of GW433908, a Prodrug of Amprenavir, in Healthy Male Volunteers

2. Emergence of Resistance to Protease Inhibitor Amprenavir in Human Immunodeficiency Virus Type 1-Infected Patients: Selection of Four Alternative Viral Protease Genotypes and Influence of Viral Susceptibility to Coadministered Reverse Transcriptase Nucleoside Inhibitors

3. Changes in Human Immunodeficiency Virus Type 1 Gag at Positions L449 and P453 Are Linked to I50V Protease Mutants In Vivo and Cause Reduction of Sensitivity to Amprenavir and Improved Viral Fitness In Vitro

4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

5. HIV update 2002: delaying treatment to curb rising resistance.

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Absence of human leukocyte antigen-B*57:01 amongst patients on antiretroviral therapy in Nigeria: Implications for use of abacavir;Nigerian Postgraduate Medical Journal;2019

2. Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States;AIDS Research and Human Retroviruses;2018-08

3. Longitudinal trends in base antiretroviral therapy utilization for human immunodeficiency virus from 2000 to 2016;Journal of the American College of Clinical Pharmacy;2018-06-28

4. An analysis of drug resistance among people living with HIV/AIDS in Shanghai, China;PLOS ONE;2017-02-10

5. HIV Protease Inhibitor Resistance;Handbook of Antimicrobial Resistance;2017